Nektar Therapeutics Appoints R. Scott Greer to Board of Directors
Feb 2, 2010
|
8.7 KB |
Nektar Therapeutics Announces Positive Topline Results for NKTR-102 From First Stage of Phase 2 Study in Platinum-Resistant Ovarian Cancer
Jan 12, 2010
|
13.5 KB |
Nektar Therapeutics Names Stephen K. Doberstein, Ph.D. Senior Vice President and Chief Scientific Officer
Jan 6, 2010
|
9.1 KB |
Nektar Therapeutics' President and CEO, Howard W. Robin, to Present at the 28th Annual J.P. Morgan Healthcare Conference in San Francisco, CA
Jan 6, 2010
|
6.2 KB |
Dennis Winger Joins Nektar Therapeutics' Board of Directors
Dec 14, 2009
|
7.1 KB |
Nektar Therapeutics Promotes Lorianne Masuoka, M.D. to Senior Vice President and Chief Medical Officer
Nov 30, 2009
|
8.7 KB |
Nektar Therapeutics Reports Third Quarter 2009 Financial Results
Nov 4, 2009
|
17.5 KB |
Nektar to Announce Financial Results for the Third Quarter of 2009 on Wednesday, November 4, 2009, After Close of U.S.-Based Financial Markets
Oct 29, 2009
|
7.1 KB |
Nektar Completes Enrollment Ahead of Schedule in Phase 2 Clinical Trial Evaluating NKTR-102 in Patients with Platinum-Resistant Ovarian Cancer
Oct 28, 2009
|
10.2 KB |
Phase 2 Data From Oral NKTR-118 Presented at American College of Gastroenterology in San Diego
Oct 27, 2009
|
11.2 KB |
Topline Results from Phase 2 Clinical Trial of Oral NKTR-118 Presented at 20th American Academy of Pain Management Annual Clinical Meeting (AAPM) in Phoenix
Oct 10, 2009
|
11.4 KB |
Nektar Therapeutics (NKTR) President and Chief Executive Officer to Ring The NASDAQ Stock Market Closing Bell
Sep 22, 2009
|
10.6 KB |
NKTR-102 Shows Encouraging Anti-Tumor Activity in Ovarian Cancer in Phase 1 and Preclinical Data Presented at the ECCO 15 and 34th ESMO Multidisciplinary Congress
Sep 22, 2009
|
10.6 KB |
Nektar Therapeutics to Host Conference Call to Discuss Today's Announcement of a New Partnership for NKTR-118 and NKTR-119
Sep 21, 2009
|
7.4 KB |
AstraZeneca and Nektar Sign Worldwide Agreement for Nektar Drug Development Programmes -- NKTR-118 and NKTR-119 -- to Address Opioid-Induced Constipation
Sep 21, 2009
|
10.9 KB |
Nektar Therapeutics to Present at the UBS 2009 Global Life Sciences Conference in New York City
Sep 18, 2009
|
6.1 KB |
Nektar Presents Data Demonstrating Favorable Oral Bioavailability and Drug-Drug Interaction Profile for NKTR-118
Sep 13, 2009
|
12.8 KB |
Nektar Therapeutics Reports Second Quarter 2009 Financial Results
Aug 4, 2009
|
16.6 KB |
Nektar Therapeutics to Present at the BMO Capital Markets 9th Annual Focus on Healthcare Conference in New York City
Jul 31, 2009
|
6.2 KB |
Nektar to Announce Financial Results for the Second Quarter of 2009 on Tuesday, August 4, 2009, After Close of U.S.-Based Financial Markets
Jul 31, 2009
|
7.5 KB |
|
|
